Table: Taiko Pharmaceutical -2017/18 group results

Taiko Pharmaceutical

11/05/2018 07:00

May 11 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             9.46            8.29           9.36                  
                 (+14.0 pct)     (-0.4 pct)     (-1.1 pct)               
  Operating         1.86            1.55           1.63                  
                 (+20.2 pct)     (+14.7 pct)    (-12.2 pct)              
  Recurring         1.57            1.41           1.43                  
                 (+11.4 pct)     (+7.7 pct)     (-8.8 pct)               
  Net
  Net               1.09            1.05           1.01                  
                 (+4.3 pct)      (+24.9 pct)    (-7.8 pct)               
  EPS             77.38 yen       76.45 yen      70.94 yen               
  EPS Diluted     77.06 yen       75.81 yen                              
  Ann Div         25.00 yen       20.00 yen      25.00 yen               
  -Q2 Div            NIL             NIL         10.00 yen               
  -Q4 Div         25.00 yen       20.00 yen      15.00 yen               
  
  NOTE - Taiko Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T